Cancer Genetics Inc (CGIX)

2.02
0.02 0.98
NASDAQ : Health Care
Prev Close 2.04
Open 2.04
Day Low/High 1.96 / 2.06
52 Wk Low/High 1.82 / 11.45
Volume 260.18K
Avg Volume 96.50K
Exchange NASDAQ
Shares Outstanding 13.65M
Market Cap 27.85M
EPS -2.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Cancer Genetics, Inc. Launches The Most Comprehensive & Clinically Actionable Next Generation Sequencing Panel In Precision Medicine, FOCUS::Lymphoma ™

Cancer Genetics, Inc. Launches The Most Comprehensive & Clinically Actionable Next Generation Sequencing Panel In Precision Medicine, FOCUS::Lymphoma ™

The Panel Provides Critical Genomic Information To Improve Patient Management & Guide Therapy Decisions

5 Breakout Stocks Under $10 Set to Soar

5 Breakout Stocks Under $10 Set to Soar

These under-$10 stocks are within range of triggering breakout trades.

Insider Trading Alert - CGIX, SAVE And BRKS Traded By Insiders

Insider Trading Alert - CGIX, SAVE And BRKS Traded By Insiders

Stocks with insider trader activity include CGIX, SAVE and BRKS

Insider Trading Alert - MAC, PNM And CGIX Traded By Insiders

Insider Trading Alert - MAC, PNM And CGIX Traded By Insiders

Stocks with insider trader activity include MAC, PNM and CGIX

7 Stocks Under $10 Making Big Moves Higher

7 Stocks Under $10 Making Big Moves Higher

These under-$10 stocks are within range of triggering breakout trades. Here's how to trade them from here.

Cancer Genetics, Inc. (CGI) To Present Results Of Collaborative Renal Biopsy And Clear Cell Renal Cell Carcinoma (ccRCC) Studies At The 2016 Genitourinary Cancer Symposium

Cancer Genetics, Inc. (CGI) To Present Results Of Collaborative Renal Biopsy And Clear Cell Renal Cell Carcinoma (ccRCC) Studies At The 2016 Genitourinary Cancer Symposium

Study Results Provide Actionable Information to Develop Customized Treatment of Renal Cell and Metastatic ccRCC Patients

Cancer Genetics, Inc. To Present Results Of Proprietary And Collaborative Next Generation Sequencing Studies Providing Actionable Clinical Data For Lymphoid And Myeloid Cancers

Cancer Genetics, Inc. To Present Results Of Proprietary And Collaborative Next Generation Sequencing Studies Providing Actionable Clinical Data For Lymphoid And Myeloid Cancers

Study Findings Will be Presented at 2015 Annual Meeting of the American Society of Hematology

5 Stocks Under $10 to Trade for Big Breakouts

5 Stocks Under $10 to Trade for Big Breakouts

These stocks trading for less than $10 a share are within range of triggering breakout trades and moving much higher from current levels.